The government agency told General Mills in a warning letter that if the cereal is being promoted for conditions that a drug could treat, it must be approved by the FDA as a drug.
The letter asserts that the cereal box was misbranded. Specifically under scrutiny is the packaging on the box and the brand's Internet advertising.
Have you registered with us yet?
Register now to enjoy more articles and free email bulletinsRegister
Already registered?Sign in
Join a growing community of PRWeek comms professionals today
- Read more articles each month
- Sign up for free specialised news bulletins